CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Xynomic Pharmaceuticals Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Xynomic Pharmaceuticals Holdings Inc
K. Wah Centre, 1010 Middle Huaihai Road
tSuite 3306
Shanghai, BEJ  200031  China
This company ceased filing statements with the SEC on 7/6/2020.
This company is no longer actively traded on any major stock exchange.
Business Summary
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. is a China-based biopharmaceutical company. The Company, together with its subsidiaries, are principally engaged in in-licensing, developing and commercializing oncology drug candidates in the People’s Republic of China (PRC), the United States, and rest of the world. To date, the Company has not yet generated any revenue from product sales.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201912/31/2019YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
6770 Blank checks
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President PeixinXu 46 12/1/2016 12/1/2016
Chief Executive Officer, Director James J.Tong 43 9/28/2017 12/1/2016
Chief Financial Officer and Principal Accounting Officer FanBu 34 9/28/2017 9/28/2017
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Xynomic Pharmaceuticals, Inc. 3500 South DuPont Highway Dover DE United States

Business Names
Business Name
BCAC
BCACU
Xu-Nuo Pharma, Inc.
XYN
XYNO
Xynomic Pharmaceuticals, Inc.

General Information
Number of Employees: 27 (As of 12/31/2019)
Outstanding Shares: 46,273,846 (As of 5/29/2020)
Stock Exchange: OTC
Federal Tax Id: 834696467
Email Address: info@xynomicpharma.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023